TY - CHAP
T1 - Recurrent and founder mutations in the Netherlands
T2 - Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation
AU - Aalberts, J. J.J.
AU - Schuurman, A. G.
AU - Pals, G.
AU - Hamel, B. J.C.
AU - Bosman, G.
AU - Hilhorst-Hofstee, Y.
AU - Barge-Schaapveld, D. Q.C.M.
AU - Mulder, B. J.M.
AU - Van Den Berg, M. P.
AU - Van Tintelen, J. P.
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Background/Methods Marfan syndrome (MFS) is a heritable connective tissue disorder usually caused by a mutation in the fibrillin 1 (FBN1) gene. Typical characteristics of MFS that have been described include dolichostenomelia, ectopia lentis and aortic root dilatation. However, there is great clinical variability in the expression of the syndrome's manifestations, both between and within families. Here we discuss the clinical variability of MFS by describing a large four-generation Dutch family with MFS. Results Nineteen individuals of one family with a single missense FBN1 mutation (c.7916A>G) were identified. The same mutation was found in one unrelated person. Clinicalvariability was extensive and not all mutation carriers fulfilled the diagnostic criteria for MFS. Some patients only expressed mild skeletal abnormalities, whereas aortic root dilation was present in eight patients, an acute type A aortic dissection was recorded in two other patients, and a mitral valve prolapse was present in eight patients. In some patients cardiac features were not present on initial screening, but did however develop over time. Conclusion MFS is a clinically highly variable syndrome, which means a meticulous evaluation of suspected cases is crucial. Mutation carriers should be re-evaluated regularly as cardiovascular symptoms may develop over time. (Neth Heart J 2010;18:85-9.).
AB - Background/Methods Marfan syndrome (MFS) is a heritable connective tissue disorder usually caused by a mutation in the fibrillin 1 (FBN1) gene. Typical characteristics of MFS that have been described include dolichostenomelia, ectopia lentis and aortic root dilatation. However, there is great clinical variability in the expression of the syndrome's manifestations, both between and within families. Here we discuss the clinical variability of MFS by describing a large four-generation Dutch family with MFS. Results Nineteen individuals of one family with a single missense FBN1 mutation (c.7916A>G) were identified. The same mutation was found in one unrelated person. Clinicalvariability was extensive and not all mutation carriers fulfilled the diagnostic criteria for MFS. Some patients only expressed mild skeletal abnormalities, whereas aortic root dilation was present in eight patients, an acute type A aortic dissection was recorded in two other patients, and a mitral valve prolapse was present in eight patients. In some patients cardiac features were not present on initial screening, but did however develop over time. Conclusion MFS is a clinically highly variable syndrome, which means a meticulous evaluation of suspected cases is crucial. Mutation carriers should be re-evaluated regularly as cardiovascular symptoms may develop over time. (Neth Heart J 2010;18:85-9.).
UR - http://www.scopus.com/inward/record.url?scp=84931353888&partnerID=8YFLogxK
U2 - 10.1007/978-90-368-0705-0_12
DO - 10.1007/978-90-368-0705-0_12
M3 - Chapter
AN - SCOPUS:84931353888
SN - 9036807042
SN - 9789036807043
SP - 89
EP - 94
BT - Founder Mutations in Inherited Cardiac Diseases in the Netherlands
PB - Bohn Stafleu van Loghum
ER -